Meet our Working Groups
This Action will include 4 Working Groups (WGs) that will be interconnected to ensure collaborative interactions throughout the Action participants in a cohesive manner.
Working Group 1
Computational methods for assessment of peptides & peptide nanostructures
Development of in silico and ML approaches to assist with the prediction and design of bioactive peptides and peptide nanostructures.
Tasks
T1.1 MD-based approaches to study the evolution of peptide nanostructures when interacting with membranes and in the cell milieu. The data extracted from this task will constitute a high-quality
dataset for T1.3.
T1.2 Data Mining (DM) approaches for effective database search to collect accurate data allowing for the identification and development of bioactive peptides & peptide nanostructures not
investigated in T1.1.
T1.3 ML approaches to speed up the design and development of bioactive peptides & peptide nanostructures, using the data produced in T1.1 and T1.2.
Milestones
Milestones M1.1: WG1 progress and the information developed from it will be disseminated in yearly meetings and will be rendered available to stakeholders to enable its use for the understanding and development of bioactive peptides, peptide nanostructures, and related products, whilst respecting Intellectual Property as required. The Action network is key to work across disciplines towards common language and recommended procedures and standards to ensure reproducibility of relevant computational processes and their appropriate description.
Working Group 2
Production & characterization of bioactive peptides & peptide nanostructures
Improve the production, sustainability, and efficiency of bioactive peptides and nanostructures while advancing their study through enhanced characterization techniques.
Tasks
T2.1 Amelioration in the production of bioactive peptides (by chemical synthesis, biotechnological tools, extraction, or other methods) and peptide nanostructures (nanofibrils, nanoparticles, nanotubes, etc.).
T2.3 Amelioration in the purification of peptides & peptide nanostructures.
T2.4 Development of advanced characterization techniques and related protocols and applications to study bioactive peptides & related nanostructures.
T2.5 Development of unified standards and protocols for best practices pertaining the characterization of bioactive peptides & related nanostructures.
Milestones
Milestone M2.1: WG2 progress and the information developed from it will be disseminated in yearly meetings and will be rendered available to stakeholders to enable its use for the understanding and development of bioactive peptides, peptide nanostructures, and related products, whilst respecting Intellectual Property as required. The Action network is key to work across disciplines towards common language and recommended procedures and standards to ensure reproducibility of relevant experimental and characterization processes and their appropriate description.
Working Group 3
Biological studies and applications of peptides & related nanostructures
To advance the knowledge pertaining the biological study of bioactive peptides & peptide nanostructures and consequently advance the applications of bioactive peptides & peptide nanostructures for healthcare (prevention, therapy & diagnosis), as well as technological uses.
Tasks
T3.1 Biological study of AMPs and related nanostructures, such as membrane-pore forming peptides.
T3.2 Biological study of amyloids & related nanostructures, including vaccine adjuvants.
T3.3 Biological study of bioactive peptides & related nanostructures for targeted therapy, drug release, and oncology.
T3.4 To advance the application of bioactive peptides & peptide nanostructures in healthcare and modern technologies.
Milestones
Milestone M3.1: WG3 progress and the information developed from it will be disseminated in yearly meetings and will be rendered available to stakeholders to enable its use for the understanding and development of bioactive peptides, peptide nanostructures, and related products, whilst respecting Intellectual Property as required. The Action network is key to work across disciplines towards common language and recommended procedures and standards to ensure reproducibility of relevant biological processes and their appropriate description and to ensure reproducible and reliable performance of the application products.
Working Group 4
Communication & Dissemination
To ensure continuous and effective dissemination within and beyond the Action throughout its duration.
Tasks
T4.1 To organize online communication on social media, official website and mailing lists within and outside the Action, including relationships with the media to boost visibility of the Action.
T4.2 To organize and promote communication through in-person meetings, and “science speed dating” to match expertise including soft skills and team building, and social moments at MC meetings.
T4.3 To organize and prepare suitable activities for training schools in line with MC decisions, webinars, and workshops for Action participants.
Milestones
Milestones M4.1: WG4 progress and related activities will be disseminated in yearly meetings, highlighting contributions and participation of YRIs and ITCs and will be rendered available to stakeholders to enable its use to efficiently train and develop the careers of scientists and stakeholders interested in the understanding and development of bioactive peptides, peptide nanostructures, and related products. The Action network is key to ensure multi- disciplinary training and shaping of a cohort of adaptable scientists with multicultural exposure to favor the social cohesiveness and integration within COST Members, Cooperating and Partner Members.
Join the Network
Whether you're an experienced researcher or an early-career scientist eager to contribute, the COST Action SNOOPY provides a collaborative, international platform for knowledge exchange, cutting-edge research, and interdisciplinary collaboration.